News from Prime Therapeutics LLC A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages.

Latest

Sep 29, 2016, 11:51 ET Prime Therapeutics Intervention Associated with Fewer High-risk Medication Refills in Medicare Population

Prime Therapeutics LLC (Prime), a pharmacy benefit manager serving over 22 million members nationally, studied the success of its...


Sep 28, 2016, 09:00 ET PrimeTherapeutics Finds Use of Short Acting Opioids Decreased, Long Acting Opioids Increased

Prime Therapeutics LLC (Prime), a pharmacy benefit manager serving over 22 million members nationally, analyzed pharmacy claims for both short and...


Sep 27, 2016, 12:51 ET Prime Therapeutics Research Finds Nearly Half of Members Discontinue Costly Rheumatoid Arthritis Drug After One Year

 Prime Therapeutics LLC (Prime), a pharmacy benefit manager serving over 22 million members nationally, analyzed members' use of rheumatoid...


Sep 23, 2016, 09:00 ET Prime Therapeutics Joins ICER as Flagship Member

Prime Therapeutics LLC (Prime), a leading pharmacy benefit manager (PBM), has joined the Institute for Clinical and Economic Review (ICER)...


Mar 08, 2016, 14:00 ET Prime Therapeutics to provide pharmacy benefits management to Blue Cross & Blue Shield of Rhode Island

 Prime Therapeutics LLC (Prime) announced today that it will begin managing pharmacy benefits for Blue Cross & Blue Shield of...


Dec 22, 2015, 16:42 ET Prime Therapeutics prefers both cholesterol lowering drugs Praluent® and Repatha® on its national drug list

 Prime Therapeutics LLC (Prime) announced today it will prefer on its national drug list, both Praluent® and Repatha®,...


Oct 26, 2015, 14:00 ET Prime Therapeutics' studies find cholesterol-lowering statins are underused

 Nationally, approximately half of patients prescribed statins as a cholesterol lowering therapy discontinue use within the first year, and...


Oct 26, 2015, 14:00 ET Prime finds breast cancer drug Ibrance taking off, signaling importance of care management

As costly, six-figure drugs continue to gain approval by Food and Drug Administration (FDA), the need for analysis and understanding of...


Oct 26, 2015, 14:00 ET New study: Prime Therapeutics' Medication Therapy Management program increases number of adherent Medicare members

 Prime Therapeutics' LLC (Prime) researchers found up to a 40 percent higher proportion of adherent Medicare members...


Mar 18, 2015, 14:00 ET First full-year look at public exchange member drug usage released by Prime Therapeutics

During the first year public health exchanges existed, Prime Therapeutics' (Prime) members who enrolled in plans on...


Feb 16, 2015, 14:00 ET Prime Therapeutics study links controlled substances score to health outcomes, cost of care

In the past decade, drug overdose deaths have more than doubled and over 50 percent were related to prescription drugs.1 To help curb this...


Jan 12, 2015, 14:00 ET Prime Therapeutics Breaks from Competition, Strikes Deals to Prefer both Harvoni, Viekira Hepatitis C Drugs

 People with Hepatitis C who are served by pharmacy benefit manager Prime Therapeutics LLC (Prime) will now have...


Dec 09, 2014, 10:29 ET Prime Therapeutics Joins the National Association of Specialty Pharmacy (NASP) as a Founding Corporate Member

The National Association of Specialty Pharmacy™ (NASP™) announced today Prime Therapeutics LLC (Prime) joined the association as a...


Dec 02, 2014, 09:00 ET Prime Therapeutics Specialty Pharmacy achieves 95 percent member satisfaction

It's no surprise people living with complex illnesses such as rheumatoid arthritis can improve their quality of life by...


Dec 01, 2014, 12:50 ET Prime Therapeutics Specialty Pharmacy to add nearly 100 jobs in Orlando

 One Orlando company has nearly doubled the size of its staff in the last two years.  And, it's adding approximately 100 more jobs by the...


Nov 17, 2014, 16:31 ET Prime Therapeutics wins Stevie® Awards for Women in Business

Ingrid Lindberg, chief customer experience officer at Prime Therapeutics LLC (Prime), and her teams were named winners of two2014 Stevie®...


Sep 30, 2014, 09:00 ET Studies show cost and use of opioid dependence treatment are increasing, spurring the need for care management programs

In 2011, approximately 5.1 million people in the United States abused prescription pain relievers (e.g. opioids).1 Clinical treatments for opioid...


Apr 29, 2014, 09:00 ET Prime Therapeutics ranks highest in customer satisfaction for two consecutive years

 For a second year, Prime Therapeutics LLC (Prime) received top rating for overall customer satisfaction and most likely to recommend for...


Apr 01, 2014, 09:00 ET Prime Therapeutics study finds high risk opioid users have medical costs three times higher than other opioid users

 People who are at high-risk for opioid abuse use had significantly higher total medical costs ($19,513 vs. $5,493) than those...


Mar 31, 2014, 09:00 ET Prime Therapeutics study finds intervention can reduce use and cost of controlled substances among high risk users

In 2010, nearly 15,000 people died from overdoses involving prescription painkillers—more than those who died from heroin...


Feb 04, 2014, 19:02 ET Prime Therapeutics Specialty Pharmacy helped nearly 20,000 members save $21.2 million on specialty medicines in 2013

 Prime Therapeutics LLC (Prime), a leading pharmacy benefit manager, helped nearly 20,000 members save more than $21.2 million...


Dec 11, 2013, 09:00 ET Prime Therapeutics wins five 2013 MarCom Awards

For the outstanding quality and creativity of its video production and business-to-business communications, Prime Therapeutics LLC (Prime), a...


Oct 14, 2013, 09:00 ET Expanded use of breast cancer drug Herceptin (trastuzumab) can be effectively tracked by combining pharmacy and medical claims data

Expanded use of the common breast cancer drug Herceptin® (trastuzumab) can be tracked using...


Oct 11, 2013, 09:00 ET Prime Therapeutics study shows wide variation in hemophilia treatment costs

 Treatment costs for the congenital bleeding disorders, hemophilia and von Willebrand's Disease (vWD) can vary substantially, from as little as...


Oct 10, 2013, 09:11 ET New Prime Therapeutics report outlines seven steps to manage high-cost specialty drugs as costs rise

 Rising costs and increased use of specialty drugs are placing a greater burden on people, their employers and their health plans. In fact,...